The UAB-HudsonAlpha Center for Genomic Medicine has awarded its first pilot grants to teams of researchers from the two institutions to pursue projects in cancer and cardiac disease.
Lower blood pressure target of 120 mm Hg greatly reduces cardiovascular complications and deaths in older adults.
UAB Hospital is the only Disease-Specific Certified program in Alabama and has had no observations or findings by The Joint Commission since joining the certification process.
Deadlines for abstracts are set for early fall and are open to graduate students, postdoctoral fellows, clinical fellows and residents.
Four projects were awarded through the first School of Medicine AMC21 Reload Multi-Investigator Grants, a broad funding opportunity provided through the Academic Enrichment Fund that enables faculty members to organize and integrate multi-disciplinary teams of accomplished investigators to compete successfully for long-term extramural support.
The protective effect is achieved by reducing acute inflammation in the spleen and the left ventricle of the heart.
UAB will receive funding from the AHA over the next four years to complete projects in population health, clinical and basic science, focused on high blood pressure.
Jennifer Pollock, Ph.D., recently received the Bodil M. Schmidt-Nielsen Distinguished Mentor and Scientist Award from the American Physiological Society.

Coghlan joined the Department of Medicine, Division of Cardiovascular Disease in 1973 and established a reputation as a beloved clinician and educator in his more than 36 years at the UAB School of Medicine.

Research revealing new evidence about the role of the spleen following heart attack will be honored during the AHA scientific meeting Nov. 15-19.
Page 1 of 3